Dymind Biotech

Medical Devices & EquipmentSeries BShenzhen, Chinadymind.com.cn

Latest round

Series B

Last raised

Apr 2018

Total raised

Undisclosed

Investors

4

About Dymind Biotech

Based in Shenzhen, China and established in 2013, Dymind Biotech operates as a medical devices developer that focuses on developing and manufacturing in vitro diagnostic devices including household ventilator for users.

Who invested in Dymind Biotech

4 investors across 2 rounds

See all investors in Dymind Biotech

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Apr 15, 2018

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Jul 19, 2016

    Amount

    Undisclosed

    Investors

    Locked

Questions about Dymind Biotech

Who invested in Dymind Biotech?

Dymind Biotech has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dymind Biotech raised?

Dymind Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Dymind Biotech last raise money?

Dymind Biotech's most recent round on record is a Series B, in Apr 2018.

What does Dymind Biotech do?

Based in Shenzhen, China and established in 2013, Dymind Biotech operates as a medical devices developer that focuses on developing and manufacturing in vitro diagnostic devices including household ventilator for users.

Where is Dymind Biotech headquartered?

Dymind Biotech is headquartered in Shenzhen, China.

Which VCs invest in companies like Dymind Biotech?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Dymind Biotech's stage. Their profiles are linked below.

Raising like Dymind Biotech? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.